
                                SEQUENCE LISTING

<110> Avive, Inc.

<120> ORAL FORMULATIONS OF A BIOLOGICALLY ACTIVE PEPTIDE AND USES THEREOF

<130> 18563-20004.40

<140> Not Yet Assigned
<141> Concurrently Herewith

<150> US 62/801,250
<151> 2019-02-05

<160> 7

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 77
<212> PRT
<213> Homo sapiens

<400> 1
Met Asn Leu Arg Leu Cys Val Gln Ala Leu Leu Leu Leu Trp Leu Ser
 1               5                  10                  15      
Leu Thr Ala Val Cys Gly Gly Ser Leu Met Pro Leu Pro Asp Gly Asn
            20                  25                  30          
Gly Leu Glu Asp Gly Asn Val Arg His Leu Val Gln Pro Arg Gly Ser
        35                  40                  45              
Arg Asn Gly Pro Gly Pro Trp Gln Gly Gly Arg Arg Lys Phe Arg Arg
    50                  55                  60                  
Gln Arg Pro Arg Leu Ser His Lys Gly Pro Met Pro Phe
65                  70                  75          


<210> 2
<211> 12
<212> PRT
<213> Homo sapiens

<400> 2
Arg Pro Arg Leu Ser His Lys Gly Pro Met Pro Phe
 1               5                  10          


<210> 3
<211> 13
<212> PRT
<213> Homo sapiens

<400> 3
Gln Arg Pro Arg Leu Ser His Lys Gly Pro Met Pro Phe
 1               5                  10              


<210> 4
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<221> VARIANT        
<222> 1
<223> Xaa = Pyroglutamate

<400> 4
Xaa Arg Pro Arg Leu Ser His Lys Gly Pro Met Pro Phe
 1               5                  10              


<210> 5
<211> 17
<212> PRT
<213> Homo sapiens

<400> 5
Lys Phe Arg Arg Gln Arg Pro Arg Leu Ser His Lys Gly Pro Met Pro
 1               5                  10                  15      
Phe
    


<210> 6
<211> 19
<212> PRT
<213> Homo sapiens

<400> 6
Arg Arg Lys Phe Arg Arg Gln Arg Pro Arg Leu Ser His Lys Gly Pro
 1               5                  10                  15      
Met Pro Phe
            


<210> 7
<211> 36
<212> PRT
<213> Homo sapiens

<400> 7
Leu Val Gln Pro Arg Gly Ser Arg Asn Gly Pro Gly Pro Trp Gln Gly
 1               5                  10                  15      
Gly Arg Arg Lys Phe Arg Arg Gln Arg Pro Arg Leu Ser His Lys Gly
            20                  25                  30          
Pro Met Pro Phe
        35      

